Polymorphs and Cocrystals of Nalidixic Acid

被引:28
作者
Gangavaram, Swarupa
Raghavender, S.
Sanphui, Palash [2 ]
Pal, Sharmistha [1 ]
Manjunatha, Sulur G. [1 ]
Nambiar, Sudhir [1 ]
Nangia, Ashwini [2 ]
机构
[1] AstraZeneca India Pvt Ltd, Pharmaceut Dev, Bangalore 560024, Karnataka, India
[2] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India
关键词
CRYSTALS;
D O I
10.1021/cg300895c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Only one X-ray crystal structure of the parent quinolone antibiotic nalidixic acid is known in the published and patent literature. A systematic search for new solid-state forms of the drug yielded two polymorphs (forms II and III) and six cocrystals with resorcinol, catechol, hydroquinone, pyrogallol, orcinol, and phloroglucinol. Of these, X-ray crystal structures were determined for polymorph II and cocrystals with resorcinol, catechol, hydroquinone, and pyrogallol, whereas the remaining solid forms were identified by their unique powder X-ray diffraction patterns. Nalidixic acid is intramolecularly O-H center dot center dot center dot O hydrogen bonded in a six-member ring, and its molecular dimers are assembled via C-H center dot center dot center dot O synthon. The OH donors on phenolic coformers H bond with the a-keto acid moiety of the drug as connectors and spacers. Intermolecular drug drug C-H center dot center dot center dot O interactions in polymorphs are replaced by strong drug-coformer O-H center dot center dot center dot O hydrogen bonds in cocrystals.
引用
收藏
页码:4963 / 4971
页数:9
相关论文
共 39 条
[11]   Solubility Advantage of Pharmaceutical Cocrystals [J].
Good, David J. ;
Rodriguez-Hornedo, Nair .
CRYSTAL GROWTH & DESIGN, 2009, 9 (05) :2252-2264
[12]   Novel furosemide cocrystals and selection of high solubility drug forms [J].
Goud, N. Rajesh ;
Gangavaram, Swarupa ;
Suresh, Kuthuru ;
Pal, Sharmistha ;
Manjunatha, Sulur G. ;
Nambiar, Sudhir ;
Nangia, Ashwini .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (02) :664-680
[13]   RAPIDLY DISSOLVING FORMS OF DIGOXIN - HYDROQUINONE COMPLEX [J].
HIGUCHI, T ;
IKEDA, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (05) :809-811
[14]   REFINEMENT OF THE STRUCTURE OF NALIDIXIC-ACID [J].
HUBER, CP ;
GOWDA, DSS ;
ACHARYA, KR .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1980, 36 (FEB) :497-499
[15]   Molecular properties of WHO essential drugs and provisional biopharmaceutical classification [J].
Kasim, Nehal A. ;
Whitehouse, Marc ;
Ramachandran, Chandrasekharan ;
Bermejo, Marival ;
Lennernas, Hans ;
Hussain, Ajaz S. ;
Junginger, Hans E. ;
Stavchansky, Salomon A. ;
Midha, Kamal K. ;
Shah, Vinod P. ;
Amidon, Gordon L. .
MOLECULAR PHARMACEUTICS, 2004, 1 (01) :85-96
[16]  
KATDARE AV, 1986, MIKROCHIM ACTA, V3, P1
[17]  
KRAUS N, 2000, POWDER CELL VERSION
[18]  
Kruthiventi A. K, 2009, WO Patent, Patent No. [136408 A1, 136408]
[19]   Polymorph control:: past, present and future [J].
Llinas, Antonio ;
Goodman, Jonathan M. .
DRUG DISCOVERY TODAY, 2008, 13 (5-6) :198-210
[20]   Monohydrous dihydrogen phosphate salts of norfloxacin and ciprofloxacin [J].
Lou, Benyong ;
Bostrom, Dan ;
Velaga, Sitaram P. .
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 2007, 63 :O731-O733